https://www.globalcures.net/post/sintilimab-asian-optimized-pd-1-checkpoint-inhibitor-by-lilly-and-innovent-biologics 2025-12-17 https://static.wixstatic.com/media/8192bb_fddee5bdbbca4a099e7e38c5fda739fb~mv2.jpg https://www.globalcures.net/post/ivonescimab 2025-02-03 https://static.wixstatic.com/media/8192bb_ac02519176064478881945687860b538~mv2.png https://www.globalcures.net/post/toripalimab-a-pd-1-inhibitor-for-multiple-solid-tumors 2025-10-31 https://static.wixstatic.com/media/8192bb_8c3876cb9f014a6787994ed6a051d73f~mv2.png https://www.globalcures.net/post/tislelizumab 2025-02-03 https://static.wixstatic.com/media/8192bb_2e651996ec3d465bb7f8eed86635e4dd~mv2.jpg https://www.globalcures.net/post/cadonilimab-a-pd-1-ctla-4-bispecific-antibody-for-cervical-cancer-and-other-solid-tumors 2025-11-01 https://static.wixstatic.com/media/8192bb_de8612677b964bc1a7d3e1c3d932bc8d~mv2.png https://www.globalcures.net/post/fruquintinib 2025-02-04 https://static.wixstatic.com/media/8192bb_9e7ab98e56064b7eb26a682d5627691a~mv2.jpg